
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
Description
About HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
The Hepatitis B Virus (HBV) genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P (P) Peptide (IEDB: 16751) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Protein P (P) Peptide, H-FLLSLGIHL-OH (Uniprot: P03158 aa: 568-575) from JPT is produced under strict quality control and quality management.
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL - Specifications
- Peptide sequence: H-FLLSLGIHL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Hepatitis
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
References:
Read References with JPT’s Antigen Peptides
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL has been described in:
Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers., Immunol Lett, 2004 (PMID: 15081620)
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection., Hepatology, 2004 (PMID: 15368433)
Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus., PLoS One, 2008 (PMID: 18806877)
Documentation
Documentation for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
Properties
Properties of HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Hepatitis |
Layout: | Freeze-dried in glass vial |
Organism: | Hepatitis B Virus (HBV) |
Protein Name: | Protein P (P) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 568-575, FLLSLGIHL
Information | Values |
---|---|
Sequence: | H-FLLSLGIHL-OH |
Specifications: | 9mer peptide as TFA salt |